Cross-Talk Between Notch and EGFR Signaling in Human Breast Cancer Cells

Notch and epidermal growth factor receptor (EGFR) signaling play critical roles in cell proliferation, differentiation, and apoptosis, and thereby may contribute to the development of breast cancer. We constitutively overexpressed active Notch1 in human breast cancer cells to explore the consequences of Notch1 signaling on cell growth and to investigate the underlying molecular mechanisms. We found that EGFR expression was increased. Then, using EGFR inhibitor, we found it exhibited an inhibitory role on human breast cancer cells. Overexpression of Notch1 could reverse EGFR inhibitor–induced cell toxicity, suggesting that Notch and EGFR signaling may be positively cross-linked in human breast cancer.

[1]  E. Wagner,et al.  EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer , 2008, Nature Cell Biology.

[2]  D. Altieri,et al.  Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. , 2008, Cancer research.

[3]  Chindo Hicks,et al.  Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. , 2008, Cancer research.

[4]  Q. Su,et al.  Notch-1 regulates transcription of the epidermal growth factor receptor through p53. , 2008, Carcinogenesis.

[5]  P. Möller,et al.  Evidence of Notch pathway activation in the ectatic ducts of chronic pancreatitis , 2008, The Journal of pathology.

[6]  Anna Marie Mulligan,et al.  JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer , 2008, Breast Cancer Research and Treatment.

[7]  J. Kuo,et al.  Developmental signaling pathways in brain tumor‐derived stem‐like cells , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[8]  M. Hollingsworth,et al.  Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins , 2007, Journal of cellular biochemistry.

[9]  A. Maity,et al.  Cellular responses to EGFR inhibitors and their relevance to cancer therapy. , 2007, Cancer letters.

[10]  R. Clarke,et al.  Mammary Stem Cells and Breast Cancer—Role of Notch Signalling , 2007, Stem Cell Reviews.

[11]  L. L. Reed,et al.  Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-κB signaling , 2007, Molecular Cancer Therapeutics.

[12]  G. Lockwood,et al.  High-level JAG1 mRNA and protein predict poor outcome in breast cancer , 2007, Modern Pathology.

[13]  K. Takaori.  Current understanding of precursors to pancreatic cancer. , 2007, Journal of hepato-biliary-pancreatic surgery.

[14]  N. Anderson,et al.  Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. , 2007, Journal of the National Cancer Institute.

[15]  S. Artavanis-Tsakonas,et al.  Crossing paths with Notch in the hyper-network. , 2007, Current opinion in cell biology.

[16]  Mitchel S Berger,et al.  Contribution of Notch signaling activation to human glioblastoma multiforme. , 2007, Journal of neurosurgery.

[17]  P. Nair,et al.  Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. , 2007, Gynecologic oncology.

[18]  R. Ma,et al.  A study on Notch signaling in human breast cancer. , 2007, Neoplasma.

[19]  M. Katoh,et al.  Notch signaling in gastrointestinal tract (review). , 2007, International journal of oncology.

[20]  Alfonso Martinez Arias,et al.  Notch, a Universal Arbiter of Cell Fate Decisions , 2006, Science.

[21]  A. Harris,et al.  Notch Signaling in Breast Cancer and Tumor Angiogenesis: Cross-Talk and Therapeutic Potentials , 2006, Journal of Mammary Gland Biology and Neoplasia.

[22]  A. Karsan,et al.  Recent insights into the role of Notch signaling in tumorigenesis. , 2006, Blood.

[23]  Zhiwei Wang,et al.  Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells , 2006, Molecular Cancer Therapeutics.

[24]  R. Clarke,et al.  Aberrant Activation of Notch Signaling in Human Breast Cancer , 2006 .

[25]  A. Ashworth,et al.  Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment , 2006, Molecular Cancer Therapeutics.

[26]  N. Daw,et al.  Evaluation of Gefitinib for Treatment of Refractory Solid Tumors and Central Nervous System Malignancies in Pediatric Patients , 2006, Cancer investigation.

[27]  I. Rebay,et al.  Signal Integration During Development: Mechanisms of EGFR and Notch Pathway Function and Cross-Talk , 2006, Critical reviews in biochemistry and molecular biology.

[28]  G. Lockwood,et al.  High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. , 2005, Cancer research.

[29]  D. Demello,et al.  A novel inflammation-induced ubiquitin E3 ligase in alveolar type II cells. , 2005, Biochemical and biophysical research communications.

[30]  A. Harris,et al.  Notch signaling from tumor cells: a new mechanism of angiogenesis. , 2005, Cancer cell.

[31]  A. El‐Naggar,et al.  Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer , 2004, Clinical Cancer Research.

[32]  Patrick Maisonneuve,et al.  Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis , 2004, The Journal of cell biology.

[33]  J. Aster,et al.  Multiple niches for Notch in cancer: context is everything. , 2004, Current opinion in genetics & development.

[34]  Xuetao Cao,et al.  Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. , 2003, Cancer research.

[35]  W. Hahn,et al.  Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells , 2002, Nature Medicine.

[36]  Tony Hunter,et al.  Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase , 2001, Molecular and Cellular Biology.

[37]  R. Callahan,et al.  Identification of a novel NOTCH-4/INT-3 RNA species encoding an activated gene product in certain human tumor cell lines , 2000, Oncogene.